Compare your results between vials
Excess weight is a well-known factor contributing to back pain
Isaacs says youre likely to experience more side effects while on higher doses of semaglutide
If you are starting semaglutide Follow the prescribed escalation schedule
Meet our doctors Last reviewed: 02 Jun 2026 Sources A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) (STEP UP), Diabetes & endocrinology [accessed 26 September 2025] MHRA approves GLP1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults, GOV.UK [accessed 26 September 2025] Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval, Reuters [accessed 26 September 2025] Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial, The Lancet [accessed 26 September 2025] Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled pen (PIL), emc [accessed 26 September 2025]
You can receive semaglutide injections through a physician-supervised program that includes consultation, dosing guidance, and follow-up monitoring
